Evidence map›Paper›PMID 36959237›Full record

ArticleScientific reports2023

Molecular simulations of SSTR2 dynamics and interaction with ligands.

Silvia Gervasoni, Camilla Guccione, Viviana Fanti, Andrea Bosin, Giancarlo Cappellini, Bruno Golosio, Paolo Ruggerone, Giuliano Malloci

Open access · goldFull text read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Macrocyclic and Hydroxamate Ligands forInorganic chemistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Silvia GervasoniDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Camilla GuccioneDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Viviana FantiDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Andrea BosinDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Giancarlo CappelliniDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Bruno GolosioDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Paolo RuggeroneDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy.
Giuliano MallociDepartment of Physics, University of Cagliari, 09042, Monserrato (Cagliari), Italy. giuliano.malloci@dsf.unica.it.
University of Cagliari · ITIstituto Nazionale di Fisica Nucleare, Sezione di Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cyclic peptide hormone somatostatin regulates physiological processes involved in growth and metabolism, through its binding to G-protein coupled somatostatin receptors. The isoform 2 (SSTR2) is of particular relevance for the therapy of neuroendocrine tumours for which different analogues to somatostatin are currently in clinical use. We present an extensive and systematic computational study on the dynamics of SSTR2 in three different states: active agonist-bound, inactive antagonist-bound and apo inactive. We exploited the recent burst of SSTR2 experimental structures to perform μs-long multi-copy molecular dynamics simulations to sample conformational changes of the receptor and rationalize its binding to different ligands (the agonists somatostatin and octreotide, and the antagonist CYN154806). Our findings suggest that the apo form is more flexible compared to the holo ones, and confirm that the extracellular loop 2 closes upon the agonist octreotide but not upon the antagonist CYN154806. Based on interaction fingerprint analyses and free energy calculations, we found that all peptides similarly interact with residues buried into the binding pocket. Conversely, specific patterns of interactions are found with residues located in the external portion of the pocket, at the basis of the extracellular loops, particularly distinguishing the agonists from the antagonist. This study will help in the design of new somatostatin-based compounds for theranostics of neuroendocrine tumours.

Indexed as

Neuroendocrine TumorsReceptors, SomatostatinGTP-Binding ProteinsHumansLigandsOctreotideSomatostatinGTP-Binding ProteinsLigandsOctreotideReceptors, SomatostatinSomatostatin

Identifiers

PMID36959237
PMCPMC10036620
OpenAlexW4360603513

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.